Mitozolomide
Mitozolomide
Mitozolomide (pronunciation: mi-to-zo-lo-mide) is a chemotherapeutic agent used in the treatment of certain types of cancer.
Etymology
The term 'Mitozolomide' is derived from the words 'mitosis' and 'lomide'. 'Mitosis' is a process of cell division that results in two daughter cells each having the same number and kind of chromosomes as the parent nucleus, typical of ordinary tissue growth. 'Lomide' is a common suffix used in the naming of pharmaceutical drugs.
Usage
Mitozolomide is primarily used in the treatment of brain tumors and melanoma, a type of skin cancer. It works by interfering with the development of cancer cells, slowing their growth and spread in the body.
Related Terms
- Chemotherapy: A type of cancer treatment that uses drugs to destroy cancer cells.
- Brain tumor: A mass or growth of abnormal cells in the brain.
- Melanoma: The most serious type of skin cancer.
- Cell division: The process by which a parent cell divides into two or more daughter cells.
- Mitosis: A type of cell division that results in two daughter cells each having the same number and kind of chromosomes as the parent nucleus.
Side Effects
Like all chemotherapeutic agents, Mitozolomide can have side effects. These may include nausea, vomiting, loss of appetite, and fatigue. More serious side effects can include low blood counts, liver problems, and allergic reactions. Patients should discuss potential side effects with their healthcare provider before starting treatment.
External links
- Medical encyclopedia article on Mitozolomide
- Wikipedia's article - Mitozolomide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski